advertisement

The Dry Eye Diet: Evidence-Based Nutraceuticals for Ocular Surface Health

Hear the latest evidence on nutraceuticals for ocular surface health and participate in an interactive, case-based clinical discussion.

Synchronous In-Person Program
1.00 available credits
Information
October 10, 2025
06:30 PM - 08:00 PM ET
Trillium Brewing
50 Thomson Pl, Boston, Massachusetts, United States
ReachMD Healthcare Image
Details
Presenters
  • Overview

    Join Program Chair Selina R. McGee, OD, FAAO, along with Mile Brujic, OD, FAAO, and Jade Coats, OD, FAAO, for this live symposium focused on the latest evidence on nutraceuticals for ocular surface health. This event will also include an interactive, case-based clinical discussion. 

  • Target Audience

    This certified continuing medical education activity is designed for optometrists. 

  • Grantor Statement

    This activity is supported by an unrestricted educational grant from Bausch + Lomb.

  • Learning Objectives

    Upon completion of this activity, learners should be better able to: 

    • Utilize diagnostic tools to accurately characterize subtypes and severity of DED
    • Summarize clinical evidence regarding nutraceutical interventions for DED
    • Integrate evidence-based nutraceutical approaches into personalized DED management plans 
  • Accreditation and Credit Designation Statements

    Evolve Medical Education LLC is a COPE-accredited administrator. 

    COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.

  • Faculty

    Selina R. McGee, OD, FAAO (Chair)
    BeSpoke Vision/Adjunct Professor
    NSUOCO
    Edmond, OK

    Mile Brujic, OD, FAAO
    Premier Vision Group
    Bowling Green, OH

    Christen Jade Coats, OD, FAAO
    Coats Eye Care
    Bentonville, AR

  • Disclosure of Relevant Financial Relationships

    DISCLOSURE POLICY
    In accordance with the COPE Standards for Integrity and Independence, it is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.

    The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.

    Selina R. McGee, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Advisory BoardOcuphireConsultantAldeyra, Alcon, Allergan, Avellino, Bausch + Lomb, Bruder, Carl Zeiss Meditec, Cynosure, DompéEyeEcoEyevance, Harrow, Horizon, Kala Pharmaceuticals, Lenz, Lumenis, Novartis, OptovueOrasisOyster Point, RVL, ScienceBased Health, Sun Pharma, Tarsus, Théa Pharma, Topcon, Versant, Vertical, Viatris, Vital Tears, and VylumaSpeaker’s Bureau: Alcon, Bausch + Lomb, Cynosure, DompéEyeEcoEyevance, Lenz, Lumenis, Oyster Point, Optovue, Sun Pharma, Tarsus. 

    Mile Brujic, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of speaking, writing, participating in an advisory capacity, research or meeting support from: ABB Optical, AbbVie, Alcon, Art Optical, Apellis Pharmaceuticals, Bausch + Lomb, Contamac, CooperVision, CSEye, Dompé, Dopavision, Glaukos, Iveric Bio, Johnson & Johnson, Lenstech, MDElite, Notal Vision, Nordic Pharma, Orasis, Radius XR, RVL, Sun Pharma, Tangible Science, Tarsus, Viatris, Visionix, Walman Optical and Zea Vision.

    Christen Jade Coats, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie Inc., Alcon Vision, Bausch & Lomb, Dompe Pharmaceuticals, Harrow Pharmaceuticals, Orasis Pharmaceuticals, Sun Pharmaceuticals, Tarsus Pharmaceuticals, Thea Pharmaceuticals, Trukera Medical. Speaker’s Bureau: Alcon Vision, Bausch & Lomb, Dompe Pharmaceuticals, Harrow Pharmaceuticals, Orasis Pharmaceuticals, Sun Pharmaceuticals, Tarsus Pharmaceuticals. Advisory Board: Zeiss.

    The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.

  • Disclaimer

    OFF-LABEL STATEMENT
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    DISCLAIMER
    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Bausch + Lomb.

    This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Details
Presenters
  • Overview

    Join Program Chair Selina R. McGee, OD, FAAO, along with Mile Brujic, OD, FAAO, and Jade Coats, OD, FAAO, for this live symposium focused on the latest evidence on nutraceuticals for ocular surface health. This event will also include an interactive, case-based clinical discussion. 

  • Target Audience

    This certified continuing medical education activity is designed for optometrists. 

  • Grantor Statement

    This activity is supported by an unrestricted educational grant from Bausch + Lomb.

  • Learning Objectives

    Upon completion of this activity, learners should be better able to: 

    • Utilize diagnostic tools to accurately characterize subtypes and severity of DED
    • Summarize clinical evidence regarding nutraceutical interventions for DED
    • Integrate evidence-based nutraceutical approaches into personalized DED management plans 
  • Accreditation and Credit Designation Statements

    Evolve Medical Education LLC is a COPE-accredited administrator. 

    COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.

  • Faculty

    Selina R. McGee, OD, FAAO (Chair)
    BeSpoke Vision/Adjunct Professor
    NSUOCO
    Edmond, OK

    Mile Brujic, OD, FAAO
    Premier Vision Group
    Bowling Green, OH

    Christen Jade Coats, OD, FAAO
    Coats Eye Care
    Bentonville, AR

  • Disclosure of Relevant Financial Relationships

    DISCLOSURE POLICY
    In accordance with the COPE Standards for Integrity and Independence, it is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.

    The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.

    Selina R. McGee, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Advisory BoardOcuphireConsultantAldeyra, Alcon, Allergan, Avellino, Bausch + Lomb, Bruder, Carl Zeiss Meditec, Cynosure, DompéEyeEcoEyevance, Harrow, Horizon, Kala Pharmaceuticals, Lenz, Lumenis, Novartis, OptovueOrasisOyster Point, RVL, ScienceBased Health, Sun Pharma, Tarsus, Théa Pharma, Topcon, Versant, Vertical, Viatris, Vital Tears, and VylumaSpeaker’s Bureau: Alcon, Bausch + Lomb, Cynosure, DompéEyeEcoEyevance, Lenz, Lumenis, Oyster Point, Optovue, Sun Pharma, Tarsus. 

    Mile Brujic, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of speaking, writing, participating in an advisory capacity, research or meeting support from: ABB Optical, AbbVie, Alcon, Art Optical, Apellis Pharmaceuticals, Bausch + Lomb, Contamac, CooperVision, CSEye, Dompé, Dopavision, Glaukos, Iveric Bio, Johnson & Johnson, Lenstech, MDElite, Notal Vision, Nordic Pharma, Orasis, Radius XR, RVL, Sun Pharma, Tangible Science, Tarsus, Viatris, Visionix, Walman Optical and Zea Vision.

    Christen Jade Coats, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie Inc., Alcon Vision, Bausch & Lomb, Dompe Pharmaceuticals, Harrow Pharmaceuticals, Orasis Pharmaceuticals, Sun Pharmaceuticals, Tarsus Pharmaceuticals, Thea Pharmaceuticals, Trukera Medical. Speaker’s Bureau: Alcon Vision, Bausch & Lomb, Dompe Pharmaceuticals, Harrow Pharmaceuticals, Orasis Pharmaceuticals, Sun Pharmaceuticals, Tarsus Pharmaceuticals. Advisory Board: Zeiss.

    The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.

  • Disclaimer

    OFF-LABEL STATEMENT
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    DISCLAIMER
    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Bausch + Lomb.

    This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Register

We're glad to see you're enjoying Eye Health Academy…
but how about a more personalized experience?

Register for free